557 related articles for article (PubMed ID: 25159276)
1. Gene therapy for the nervous system: challenges and new strategies.
Maguire CA; Ramirez SH; Merkel SF; Sena-Esteves M; Breakefield XO
Neurotherapeutics; 2014 Oct; 11(4):817-39. PubMed ID: 25159276
[TBL] [Abstract][Full Text] [Related]
2. Viral vectors and delivery strategies for CNS gene therapy.
Gray SJ; Woodard KT; Samulski RJ
Ther Deliv; 2010 Oct; 1(4):517-34. PubMed ID: 22833965
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system.
Zlokovic BV; Apuzzo ML
Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854
[TBL] [Abstract][Full Text] [Related]
4. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
[TBL] [Abstract][Full Text] [Related]
5. Liposomal and viral vectors for gene therapy of the central nervous system.
de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP
Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications involving CNS gene transfer.
Kantor B; McCown T; Leone P; Gray SJ
Adv Genet; 2014; 87():71-124. PubMed ID: 25311921
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy and neurodevelopmental disorders.
Gray SJ
Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
Saraiva J; Nobre RJ; Pereira de Almeida L
J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
[TBL] [Abstract][Full Text] [Related]
9. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.
Puhl DL; D'Amato AR; Gilbert RJ
Brain Res Bull; 2019 Aug; 150():216-230. PubMed ID: 31173859
[TBL] [Abstract][Full Text] [Related]
10. Viral vectors for gene delivery to the central nervous system.
Lentz TB; Gray SJ; Samulski RJ
Neurobiol Dis; 2012 Nov; 48(2):179-88. PubMed ID: 22001604
[TBL] [Abstract][Full Text] [Related]
11. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
12. Crossing the blood-brain-barrier with viral vectors.
Fu H; McCarty DM
Curr Opin Virol; 2016 Dec; 21():87-92. PubMed ID: 27591676
[TBL] [Abstract][Full Text] [Related]
13. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
Joshi CR; Labhasetwar V; Ghorpade A
J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
Zlokovic BV; Apuzzo ML
Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
[TBL] [Abstract][Full Text] [Related]
15. Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs.
Leong TW; Pal A; Cai Q; Gao Z; Li X; Bleris L; Hayenga HN; Qin Z
J Control Release; 2023 May; 357():511-530. PubMed ID: 37040842
[TBL] [Abstract][Full Text] [Related]
16. The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System.
Piguet F; de Saint Denis T; Audouard E; Beccaria K; André A; Wurtz G; Schatz R; Alves S; Sevin C; Zerah M; Cartier N
Hum Gene Ther; 2021 Apr; 32(7-8):349-374. PubMed ID: 33167739
[TBL] [Abstract][Full Text] [Related]
17. Critical issues in gene therapy for neurologic disease.
Hsich G; Sena-Esteves M; Breakefield XO
Hum Gene Ther; 2002 Mar; 13(5):579-604. PubMed ID: 11916483
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound targeted CNS gene delivery for Parkinson's disease treatment.
Fan CH; Lin CY; Liu HL; Yeh CK
J Control Release; 2017 Sep; 261():246-262. PubMed ID: 28690161
[TBL] [Abstract][Full Text] [Related]
19. Adeno-Associated Virus Vector for Central Nervous System Gene Therapy.
Zhu D; Schieferecke AJ; Lopez PA; Schaffer DV
Trends Mol Med; 2021 Jun; 27(6):524-537. PubMed ID: 33895085
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies.
Padmakumar S; D'Souza A; Parayath NN; Bleier BS; Amiji MM
J Control Release; 2022 Dec; 352():121-145. PubMed ID: 36252748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
